Correct, I won't buy the likes of ICPT, these developmental biotech stocks are lunacy, not investing but gambling. Take it from me, I lost many many thousands on such biotech hopes. GW Pharma at least is the only legitimate company in the space, I'll give them that.
Fortunately I made back years of such biotech losses by investing in real companies like GILD AMGN CELG BIIB
If you wanna gamble.... have fun.
I'm not a hater... nor a shareholder.
Why the haters ?
Probably because the company is estimated to loose $3.14 per share this year, $4.14 per share for 2016. No estimated beyond that. But that carries enough risk to say that at $110, this issue is likely overvalued. It will be volatile for months to come.
Hold at your own risk.